Stock Reversals

Gene Therapy Attack Capital Time? QURE

UniQure (NASDAQ:QURE) is delivering on the promise of gene therapy, single treatments with potentially curative results. We have developed a modular platform to …

Jan 30th Weekend Edition- Greater Fool Theory-IPO Hype

Another rough and tumble week ending with the SP 500 down sharply 3 straight days ending the week around 1994, just 4 points …

Biotech Stock Updates and More

NASDAQ: CHRS– We recommended investors buy Coherus a few weeks ago under the IPO price when it was trading around $13.10.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts